ArticleFrontiers in medicine2026
Sensory processing sensitivity levels in patients with disorders of gut-brain interaction: a propensity score-matched cross-sectional study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Although sensory processing sensitivity (SPS) has been extensively studied in the context of psychological health, its potential association with disorders of gut-brain interaction (DGBI) remains poorly understood. Objective: This study used the Chinese version of the Highly Sensitive Person (HSP) Scale to assess sensory processing sensitivity (SPS) levels and the prevalence of highly sensitive persons (HSPs) in a DGBI cohort. Using propensity score matching (PSM), it aimed to compare these metrics between DGBI patients and healthy controls and to evaluate the discriminative capacity of SPS for DGBI. Additionally, SPS and HSP distribution were compared across DGBI subgroups categorized by upper versus lower gastrointestinal (GI) symptom predominance. Methods: SPS levels were assessed using the validated Chinese Highly Sensitive Person Scale (HSPS-C). Covariate balance was achieved through 1:1 PSM. Intergroup disparities were examined using independent samples * Results: Post-PSM analysis (254 matched pairs) revealed significantly higher total SPS scores in the DGBI group versus controls ( Conclusion: Elevated SPS levels are significantly associated with DGBI. However, the subgroup analysis revealed no significant differences in SPS levels or HSP distribution between patients with upper and lower gastrointestinal DGBI. Early identification of HSP characteristics may nevertheless facilitate personalized interventions, supporting the integration of SPS assessment into DGBI diagnostic and management frameworks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.